Related references
Note: Only part of the references are listed.A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers
Liping Sun et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
The Amyloid-beta Oligomer Hypothesis: Beginning of the Third Decade
Erika N. Cline et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Detection of cognitive impairment using a machine-learning algorithm
Young Chul Youn et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
Jun Wang et al.
Nature Reviews Neurology (2017)
Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42
Seong Soo A. An et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease
Min Jeong Wang et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay
Katja Kuehbach et al.
FRONTIERS IN NEUROSCIENCE (2016)
Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density
Craig Curtis et al.
JAMA NEUROLOGY (2015)
Plasma Amyloid-β Oligomers and Soluble Tumor Necrosis Factor Receptors as Potential Biomarkers of AD
Jinbiao Zhang et al.
CURRENT ALZHEIMER RESEARCH (2014)
Sample size estimation in diagnostic test studies of biomedical informatics
Karimollah Hajian-Tilaki
JOURNAL OF BIOMEDICAL INFORMATICS (2014)
Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology
Katherine A. Price et al.
MOLECULAR NEURODEGENERATION (2014)
Alzheimer's Therapeutics Targeting Amyloid Beta 1-42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits
Nicholas J. Izzo et al.
PLOS ONE (2014)
Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
Anne M. Fagan et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Plasma amyloid-β oligomers level is a biomarker for Alzheimer's disease diagnosis
L. Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
Thomas G. Beach et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
Ji Won Um et al.
NATURE NEUROSCIENCE (2012)
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
Michael Scholl et al.
NEUROLOGY (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA (2011)
Urine Neural Thread Protein Measurements in Alzheimer Disease
Young Chul Youn et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2011)
Studies of the Growth, Evolution, and Self-Aggregation of β-Amyloid Fibrils Using Tapping-Mode Atomic Force Microscopy
Wilson K. Serem et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2011)
Differentiating blood samples from scrapie infected and non-infected hamsters by detecting disease-associated prion proteins using Multimer Detection System
S. S. A. An et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer Disease
Nigel J. Cairns et al.
ARCHIVES OF NEUROLOGY (2009)
Inflammatory markers in AD and MCI patients with different biomarker profiles
Alie Schuitemaker et al.
NEUROBIOLOGY OF AGING (2009)
Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction
Jennifer L. Tomic et al.
NEUROBIOLOGY OF DISEASE (2009)
An adaptation of the Korean mini-mental state examination (K-MMSE) in elderly Koreans: Demographic influence and population-based norms (the AGE study)
Changsu Han et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2008)
Serum Amyloid P Component as a Biomarker in Mild Cognitive Impairment and Alzheimer's Disease
Nicolaas A. Verwey et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Amyloid β protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease
PD Mehta et al.
NEUROSCIENCE LETTERS (2001)
Amyloid-β peptides interact with plasma proteins and erythrocytes:: Implications for their quantitation in plasma
YM Kuo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
